If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChemring Regulatory News (CHG)

Share Price Information for Chemring (CHG)

Share Price is delayed by 15 minutes
Get Live Data
577.50    5.50 (0.96%)
Bid:
577.00
Ask:
577.50
Spread: 0.50 (0.087%)
Market Cap: £1.56b
CHG Live PriceLast checked at - London Stock Exchange

Intraday Chemring Share Chart

Directorate Change

24 Jun 2014 07:00

RNS Number : 3280K
Chemring Group PLC
24 June 2014
 



 FOR IMMEDIATE RELEASE 24 JUNE 2014

 

CHEMRING GROUP PLC

 

Directorate change

 

Michael Flowers appointed Group Chief Executive

 

Chemring Group PLC ("Chemring" or "the Group") announces that Michael Flowers has been appointed Group Chief Executive with immediate effect. Michael joined Chemring in 2006 and prior to today's appointment was Group Director, Countermeasures and a member of Chemring's Executive Committee.

 

Michael Flowers has spent 13 years in senior management positions within the defence industry. He previously served as an officer in the Australian Army for 22 years and was a graduate of the Australian Command and Staff College and the British Royal Military College of Science. After leaving the army, he was a senior manager at BAE Systems from 2001 to 2006, in programme and project management roles.

 

From 2006, he was Managing Director, Chemring Australia, where he established a state of the art countermeasures manufacturing facility and delivered substantial growth in the defence portfolio. In 2013, he was appointed Group Director, Munitions, with responsibility for Chemring's European munitions business. Michael led the successful sale of the European munitions business following the 2013 strategic review, working closely with Chemring's Board and advisers to negotiate and complete the disposal in May 2014.

 

Mark Papworth has stepped down from the Board of Chemring with immediate effect. 

 

Peter Hickson, Chairman of Chemring, said:

 

"Michael Flowers has a proven track record, both within the international defence industry and within Chemring, where he led our Australian business through a successful period of growth and, more recently, managed the complex disposal process of the European munitions business. Michael is extremely knowledgeable about our markets and is well qualified to lead Chemring as we capitalise on our world leading technologies in Countermeasures, Sensors & Electronics and Energetic Systems.

 

Much has been achieved during Mark Papworth's tenure, including a significant reorganisation and refocusing of the Group and a substantial reduction in the cost base and we are grateful for his leadership during this period.

 

We are now moving from a period of critical and significant change to one where we must take maximum advantage of the stronger platform that has been created. To achieve this, a different set of skills is required in the role of Chief Executive, in particular extensive knowledge and understanding of the defence markets in which we operate."

 

Michael Flowers has a beneficial shareholding of 80,680 Chemring shares.

 

There is no further information to be disclosed pursuant to paragraph 9.6.13R of the UK Listing Rules in relation to Michael Flowers' appointment as a director of Chemring.

 

Ends

 

 

 

 

For further information, contact:

 

Chemring Group PLC 01489 881 880

Peter Hickson, Chairman

Steve Bowers, Finance Director

Rupert Pittman, Group Director of Communications and Investor Relations

 

MHP Communications 020 3128 8100

Andrew Jaques

John Olsen

James White

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOADDGDLSBDBGSX
Date   Source Headline
17th Dec 20207:00 amRNSDirector/PDMR Shareholding
16th Dec 20201:17 pmRNSDirector/PDMR Shareholding
16th Dec 20201:15 pmRNSDirector/PDMR Shareholding
16th Dec 20201:13 pmRNSDirector/PDMR Shareholding
15th Dec 20207:00 amRNSFinal Results
1st Dec 202011:17 amRNSTotal Voting Rights
27th Nov 20204:41 pmRNSSecond Price Monitoring Extn
27th Nov 20204:36 pmRNSPrice Monitoring Extension
6th Nov 20205:04 pmRNSHolding(s) in Company
4th Nov 20202:53 pmRNSHolding(s) in Company
3rd Nov 20207:00 amRNSTrading Update
2nd Nov 20205:13 pmRNSHolding(s) in Company
2nd Nov 20201:25 pmRNSTotal Voting Rights
23rd Oct 202010:53 amRNSHolding(s) in Company
15th Oct 20204:14 pmRNSHolding(s) in Company
2nd Oct 202012:31 pmRNSHolding(s) in Company
2nd Oct 202010:36 amRNSDirector/PDMR Shareholding
1st Oct 20205:48 pmRNSTotal Voting Rights
30th Sep 20207:00 amRNSContract Awards
24th Sep 20204:08 pmRNSHolding(s) in Company
16th Sep 202012:02 pmRNSPrice Monitoring Extension
15th Sep 202012:02 pmRNSPrice Monitoring Extension
15th Sep 202011:03 amRNSHolding(s) in Company
15th Sep 20207:00 amRNSTrading Update
11th Sep 202011:49 amRNSHolding(s) in Company
1st Sep 202011:34 amRNSTotal Voting Rights
27th Aug 202012:08 pmRNSSecond Price Monitoring Extn
27th Aug 202012:02 pmRNSPrice Monitoring Extension
26th Aug 202012:02 pmRNSPrice Monitoring Extension
21st Aug 20202:44 pmRNSHolding(s) in Company
17th Aug 202012:02 pmRNSPrice Monitoring Extension
12th Aug 202011:30 amRNSHolding(s) in Company
3rd Aug 20209:54 amRNSTotal Voting Rights
31st Jul 202012:07 pmRNSSecond Price Monitoring Extn
31st Jul 202012:02 pmRNSPrice Monitoring Extension
30th Jul 202011:22 amRNSDirector/PDMR Shareholding
30th Jul 202011:18 amRNSDirector/PDMR Shareholding
14th Jul 202012:07 pmRNSSecond Price Monitoring Extn
14th Jul 202012:02 pmRNSPrice Monitoring Extension
10th Jul 202012:07 pmRNSSecond Price Monitoring Extn
10th Jul 202012:02 pmRNSPrice Monitoring Extension
8th Jul 202012:07 pmRNSSecond Price Monitoring Extn
8th Jul 202012:02 pmRNSPrice Monitoring Extension
7th Jul 20204:02 pmRNSHolding(s) in Company
6th Jul 20202:03 pmRNSHolding(s) in Company
6th Jul 20201:58 pmRNSHolding(s) in Company
2nd Jul 202012:02 pmRNSPrice Monitoring Extension
1st Jul 202011:36 amRNSTotal Voting Rights
22nd Jun 20204:26 pmRNSDirector/PDMR Shareholding
19th Jun 20209:34 amRNSBlock listing update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.